Zeus Capital adds three to team

Zeus Capital has hired Alistair Donnelly and Jordan Warburton as executives for the firm’s corporate finance team. Also, the UK-based investment bank has appointed Claire Duffy as research executive. Previously, Donnelly worked at KPMG; Warburton was at EY; and Duffy came from Daniel Stewart.

PRESS RELEASE

Investment banking boutique Zeus Capital has made a trio of hires in its Manchester office as it looks to build upon its strong recent performance.

Alistair Donnelly and Jordan Warburton have been appointed as executives in the firm’s corporate finance team, while Claire Duffy takes the role of research executive.

Alistair joins Zeus Capital from KPMG, where he had spent five years. He spent eighteen months in the accountancy firm’s corporate finance team, advising on large infrastructure-related projects across both public and private markets. Prior to that, he worked in the firm’s audit team on clients including Manchester Airport Group and On The Beach.

Jordan started his career as an intern at EY, and joined the firm full time in 2012. He was executive in the transaction advisory services team specialising in corporate restructuring. Claire Duffy joins from Daniel Stewart, where she spent over eight years in the firm’s research team, in addition to previous roles at Numis and Charterhouse Securities.

These appointments build on Zeus Capital’s recent success in the market. The firm has been at the heart of many of the North West’s biggest deals, advising on the £200m reverse takeover of Matthew Clark by Conviviality Retail, as well as the flotation of Elegant Hotels and the reverse takeover of BCA Marketplace.

Tremayne Ducker, head of private company and private equity at Zeus Capital, said: “Zeus Capital continues to invest in building its team in order to pursue ambitious growth plans. These latest appointments will help to provide additional resource to support our clients and senior team, and provide further knowledge and expertise.

“Alistair, Claire and Jordan all have enormous potential, and underline the commitment that we have made to building and developing the next generation. We have enjoyed an excellent couple of years, advising on some of the largest deals in the region, and we’re confident that we have the team to continue this momentum into next year.”

These appointments are also supplemented by the acquisition of broker Novum Securities, and the extension of the firm’s London team, adding a number of senior positions.

Zeus Capital is an independent investment banking boutique, providing advisory and fundraising services across public, private and trade transactions. The firm was established in 2003 and clients include public and privately owned companies, along with key players in the private equity community. Zeus Capital has offices in London, Manchester and Birmingham.

Zeus has recently acted on a number of high profile IPOs as Nominated Adviser and Broker and was ranked number one by IPO funds raised on AIM in H1 2014 and in the top 20 for IPO funds raised globally.

Recent transactions Zeus has advised on include:
· £1.2bn listing and associated £1.03bn equity fundraise for used vehicle marketplace, BCA Marketplace (HAV.L)
· £560m listing of online fashion retailer boohoo.com and associated fundraising of £300m (BOO)
· £200m listing and associated £193m fundraise of logistics and parcel distribution company DX (Group) (DX)
· £340m listing and associated £115m fundraise for flash sales company, MySale (MYSL)
· £135m listing and associated £94m placing of integrated, light-side building materials company, Epwin Group (EPWN)
· £125m listing and associated £100m fundraise for pharmaceuticals supplier and manufacturer, Quantum Pharma (QP.L)
· £78m listing and associated £70m placing of retail home improvements business, Safestyle UK (SFE)
· £66m listing and associated £64m placing of
off – licence retailer, Conviviality Retail (CVR)
· £40m listing and placing of the UK’s leading distributor of fluid power products, Flowtech Fluidpower (FLO)
· £36.5m listing including £16.5m fundraise of pharmaceuticals company 4d pharma, with subsequent £21.5m secondary raise (DDDD)
· £32.5m listing including £7m fundraise of internet TLD company, CentralNic (CNIC)